Skip to content
value.today

Tioga Pharmaceuticals Inc

🇺🇸 San Diego, California, USAPharmaceuticalsFounded 2005

Formerly Icon Pharmaceuticals, Inc.

Total raised
$24 M
4 rounds on record
Latest round
$10 M
Apr 2012
First round on record
Apr 2009
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Tioga Pharmaceuticals Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2012$10 MNo. 4$10 to $50 million

Tioga Pharmaceuticals Inc: Raise no. 4, Apr 2012

Investors in this round

4 investors had bought by the notice of Apr 10, 2012: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allen M. Mangel · Executive Officer
  • David M. Urso · Executive Officer, Director
  • Gareth M. Hicks · Executive Officer
  • Stuart J.M. Collinson · Executive Officer, Director
  • Arno M. Hartmann · Director
  • James M. Niedel · Director
  • Jason M. Brown · Director
  • Martin M. Muenchbach · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David M. Urso, COO and General Counsel. Source: SEC Form D, newest notice filed Apr 10, 2012. Read the notice at the SEC.

equitySEC
Feb 2010$9 MNo. 3$2 to $10 million

Tioga Pharmaceuticals Inc: Raise no. 3, Feb 2010

Investors in this round

4 investors had bought by the notice of Feb 22, 2010: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $18 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allen M. Mangel · Executive Officer
  • David M. Urso · Executive Officer, Director
  • Stuart J.M. Collinson · Executive Officer, Director
  • Arno M. Hartmann · Director
  • James M. Niedel · Director
  • Martin M. Muenchbach · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Does not include amounts receivable upon exercise of warrants, which cannot be determined at this time.”

Signed by David M. Urso, COO and General Counsel. Source: SEC Form D, newest notice filed Feb 22, 2010. Read the notice at the SEC.

equity, optionsSEC
Sep 2009$3 MNo. 2$2 to $10 million

Tioga Pharmaceuticals Inc: Raise no. 2, Sep 2009

Investors in this round

3 investors had bought by the notice of Oct 26, 2009: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Allen M. Mangel · Executive Officer
  • David M. Urso · Executive Officer, Director
  • Stuart J.M. Collinson · Executive Officer, Director
  • Arno M. Hartmann · Director
  • James M. Niedel · Director
  • Martin M. Meunchbach · Director · Address: Guernsey, Channel Islands GY1 3QL

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Does not include amounts receivable upon exercise of warrants, which cannot be determined at this time.”

Signed by David M. Urso, Chief Operating Officer and General Counsel. Source: SEC Form D, newest notice filed Oct 26, 2009. Read the notice at the SEC.

debt, optionsSEC
Apr 2009$2 MNo. 1$2 to $10 million

Tioga Pharmaceuticals Inc: Raise no. 1, Apr 2009

Investors in this round

3 investors had bought by the notice of May 27, 2009: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in De

People named in the notice

  • David M. Urso · Executive Officer, Director
  • Stuart J.M. Collinson · Executive Officer, Director
  • Arno Hartmann · Director
  • James Niedel · Director
  • Martin Meunchbach · Director · Address: Guernsey, Channel Islands GY1 3QL

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Does not include amounts receivable upon exercise of warrants, which cannot be determined at this time.”

Signed by David M. Urso, Chief Operating Officer and General Counsel. Source: SEC Form D, newest notice filed May 27, 2009. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Tioga Pharmaceuticals Inc chose not to state its revenue in its newest notice of a funding round (Apr 2012).

    SEC Form D · Apr 2012

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Apr 2012

That is all the official record says: Tioga Pharmaceuticals Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Tioga Pharmaceuticals Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 4 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Tioga Pharmaceuticals Inc
NameRoleNamed in
Allen M. MangelExecutive officerApr 2012
David M. UrsoExecutive officerApr 2012
Gareth M. HicksExecutive officerApr 2012
Stuart J.M. CollinsonExecutive officerApr 2012
Arno M. HartmannDirectorApr 2012
David M. UrsoDirectorApr 2012
James M. NiedelDirectorApr 2012
Jason M. BrownDirectorApr 2012
Martin M. MuenchbachDirectorApr 2012
Stuart J.M. CollinsonDirectorApr 2012
Martin M. MeunchbachAddress: Guernsey, Channel Islands GY1 3QLOct 2009
Arno HartmannDirectorMay 2009
James NiedelDirectorMay 2009
Martin MeunchbachAddress: Guernsey, Channel Islands GY1 3QLMay 2009